PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects (Q28288812)

2

0 references

Frank S David

3

0 references

David Barford

4

0 references

Benjamin G Neel

Journal of Biological Chemistry

5

0 references

language of work or name

English

0 references

publication date

10 March 2006

0 references

published in

0 references

volume

281

0 references

issue

10

0 references

page(s)

6785-92

0 references

cites work

Noonan syndrome and related disorders: genetics and pathogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

PTPN11 mutations in LEOPARD syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Noonan syndrome: the changing phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Multiple Lentigenes Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Crystal structure of human protein tyrosine phosphatase 1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Form and function in protein dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by x-ray crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Heart valve development: endothelial cell signaling and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Nf1 has an essential role in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

Cell migration: integrating signals from front to back

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

The protein tyrosine phosphatase Shp-2 regulates RhoA activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200

SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513068200